Advertisement

Topics

Hollis-Eden Pharmaceuticals Company Profile

00:03 EDT 23rd June 2018 | BioPortfolio

Hollis-Eden Pharmaceuticals is a development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of a number of targeted disease states caused byviral, bacterial, parasitic or fungal infections, including HIV/AIDS, hepatitis B and C, and malaria. The Company has three technology platforms, one based on cellular energy regulation, the second on a unique immune system modulation technology, and the third on biochemical synthesis regulators. The Company believes that certain of its drug candidates may provide the first long-term treatment for HIV without the development of viral strain resistance to the drugs' effectiveness, significant toxicity or severe side effects.

Location

4435 Eastgate Mall
Suite, 400
San Diego
CA
92121
United States of America

Contact

Phone: (858)587-9333
Fax: (858)558-6470
Email: Info@holliseden.com


News Articles [506 Associated News Articles listed on BioPortfolio]

Henry Hollis

bmj;361/apr05_8/k1444/FAF1faBorn in Thistleton, Rutland, Henry Hollis attended the King’s School in Grantham and the London Hospital Medical College during the war. In lieu of national service he......

MSU Athletic Director Mark Hollis Resigns In Wake Of Larry Nassar Scandal

Michigan State University athletic director Mark Hollis resigned Friday, two days after disgraced physician Larry Nassar was sentenced for seven counts of first-degree criminal sexual conduct, The As...

Eden Research starts to bloom as Mevalone sales ratchet up

Eden has already started looking at possibilities well beyond wine

Eden Research sales jump as wine producers warm to natural pesticide

Eden uses terpenes produced by plants as the basis of its products

Eden Research PLC keen to add US to list of markets for natural fungicide

Sean Smith, chief executive of Eden Research PLC, explains the technology behind its range of naturally-derived pesticides and why winegrowers in France, Spain and Italy are giving rave reviews...

Eden by Perrier-Jouët leva visitantes do centro de Tóquio para a Épernay subterrânea

TÓQUIO, 10 de maio de 2018 /PRNewswire/ -- Para acompanhar a Semana do Design de Tóquio, o Eden by Perrier-Jouët está fazendo sua terceira visita Read more...

Eden by Perrier-Jouët Takes Visitors From Downtown Tokyo to Underground Epernay

To view the Multimedia News Release, please click:   http://www.multivu.com/players/uk/8325851-eden-perrier-jouet-downtown-tokyo-epernay/ A pioneer of Art Nouveau, Perrier-Jouët is now using dig...

Jill Vitale-Aussem to Serve as New President and CEO of The Eden Alternative®

A 24-year old global, non-profit organization, The Eden Alternative chooses a new leader to help drive forward its commitment to transforming the culture of care. ROCHESTER, N.Y. (PRWEB) May 03, 2018 ...

PubMed Articles [139 Associated PubMed Articles listed on BioPortfolio]

In the Garden of Eden: The Content of My Psychoses.

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Clinical Trials [226 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of Gene-Eden-VIR/Novirin

This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.

Latarjet Versus Modified Eden-Hybinnette for Anterior Shoulder Dislocation

Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinnett (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1338 Associated Companies listed on BioPortfolio]

Hollis-Eden Pharmaceuticals, Inc.

Hollis-Eden Pharmaceuticals is a development-stage company with two product candidates in clinical trials: Apoptone® (HE3235), in the dose-escalation portion of a Phase I/II trial of patients with la...

Hollis-Eden Pharmaceuticals

Hollis-Eden Pharmaceuticals is a development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of a number of targeted disease ...

Next-Generation Pharmacist

Civic Leader of the Year: Peter Crouch, RPh, CCP, Eden Drug, Eden, N.C.

Eden Biodesign Ltd.

Eden Biodesign is a globally-integrated biopharmaceutical company offering consultancy, biopharmaceutical design, process development and cGMP manufacturing services to leading bi...

Eden Biodesign

Eden Biodesign is an integrated biopharmaceutical development organisation that evolved out of Eden Biopharm, a successful international development and manufacturing consultancy. Eden Biodesign is th...

More Information about "Hollis-Eden Pharmaceuticals" on BioPortfolio

We have published hundreds of Hollis-Eden Pharmaceuticals news stories on BioPortfolio along with dozens of Hollis-Eden Pharmaceuticals Clinical Trials and PubMed Articles about Hollis-Eden Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hollis-Eden Pharmaceuticals Companies in our database. You can also find out about relevant Hollis-Eden Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...


Corporate Database Quicklinks



Searches Linking to this Company Record